Clinical Trials Logo

Recurrent Atrial Fibrillation clinical trials

View clinical trials related to Recurrent Atrial Fibrillation.

Filter by:
  • None
  • Page 1

NCT ID: NCT05776797 Recruiting - Clinical trials for Persistent Atrial Fibrillation

AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation

AMPER-AF
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.

NCT ID: NCT03467126 Not yet recruiting - Clinical trials for Recurrent Atrial Fibrillation

AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation (RECOVER AF)

RECOVER AF
Start date: January 2019
Phase: N/A
Study type: Interventional

A prospective, single-arm, multi-center, non-randomized, pre-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure.

NCT ID: NCT03368781 Completed - Clinical trials for Recurrent Atrial Fibrillation

AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation

RECOVER AF
Start date: April 12, 2018
Phase: N/A
Study type: Interventional

A prospective, single-arm, multi-center, multi-national, non-randomized, post-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure. (CLP-AF-004 [EU]) A prospective, single-arm, multi-center, non-randomized, pre-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure. (CLP-AF-005 [Canada])

NCT ID: NCT02459574 Completed - Heart Failure Clinical Trials

Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation

AVATAR-AF
Start date: May 1, 2015
Phase: N/A
Study type: Interventional

A streamlined AF ablation procedure done without PV mapping as a daycase is more effective than anti-arrhythmic drugs at reducing all hospital episodes for recurrent atrial fibrillation.